Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 6.59SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.
Health Score : 6.59SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
23.93
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
22.25
P/B RATIO
2.17
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
1.29
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
1.52
EV/EBITDA RATIO
8.88
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1480 as on Sep 1, 2026.
Growth Score : 10.00The growth ratios display a strong upward trend, showing SMS Lifesciences is significantly expanding. High growth in revenue, operating profit, EPS, assets, and net income indicates robust business performance. This growth reflects effective strategies and market positioning. The company is experiencing substantial expansion across various financial metrics. The weighted average calculation underscores the consistent and strong growth trajectory.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 1.92 | 31.58 | -9.71 | -3.16 | 12.75 |
| Operating Profit Growth Rate | 20 | 16.67 | -17.14 | 6.9 | 45.16 |
| Earnings Per Share (EPS) Growth | 33.2 | 86.73 | -54.73 | -20.68 | 121.22 |
| Asset Growth Rate | 18.21 | 10.64 | -1.01 | -0.26 | |
| Net Income Growth Rate | 40 | 78.57 | -56 | -45.45 | 216.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | KILITCH | 7.12 | 22.83 | Neutral | 37.00 | 9.27 | 30.00 |
| 2 | MEDICO | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 3 | KOPRAN | 6.60 | 40.82 | Undervalued | 62.00 | 6.30 | 26.00 |
| 4 | SMSLIFE | 6.59 | 22.25 | Undervalued | 45.00 | 58.80 | 19.00 |
| 5 | INFINIUM | 6.42 | 33.97 | Neutral | 22.00 | 6.43 | 14.00 |
| 6 | MEDICAMEQ | 5.73 | 37.61 | Neutral | 20.00 | 6.94 | 10.00 |
| 7 | AAREYDRUGS | 5.73 | 60.35 | Neutral | 7.00 | 1.40 | 4.00 |
| 8 | ALBERTDAVD | 5.63 | -333.98 | Neutral | 5.00 | -2.62 | -1.00 |
| 9 | BPL | 5.46 | -28.58 | Neutral | -4.82 | -1.69 | -8.55 |
| 10 | ZIMLAB | 5.41 | 108.20 | Neutral | 30.00 | 1.11 | 6.00 |
| 11 | LYKALABS | 4.77 | -26.63 | Neutral | -4.00 | -8.93 | -10.00 |
| 12 | NECLIFE | 3.83 | -0.80 | Neutral | -59.00 | -2.95 | -293.00 |
| 13 | PANCHSHEEL | N/A | N/A | N/A | N/A | N/A | N/A |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
SMS Lifesciences India Ltd. is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, primarily serving the pharmaceutical sector. The company specializes in developing and producing a diverse range of products across various therapeutic categories. Operating state-of-the-art facilities, it caters to both domestic and international markets, positioning itself as a key supplier in the global pharmaceutical supply chain.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. SMS Lifesciences India Ltd's P/E ratio (TTM) is 23.93, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. SMS Lifesciences India Ltd's P/B ratio is 2.17, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. SMS Lifesciences India Ltd's P/S ratio is 1.29, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. SMS Lifesciences India Ltd's PEG ratio is 1.52.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. SMS Lifesciences India Ltd's EV/EBITDA ratio is 8.88.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. SMS Lifesciences India Ltd's ROE is 9.64%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. SMS Lifesciences India Ltd's ROA is 11.54%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. SMS Lifesciences India Ltd's ROCE is 12%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. SMS Lifesciences India Ltd's operating margin is 13.04%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. SMS Lifesciences India Ltd's net margin is 5.51%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. SMS Lifesciences India Ltd's current ratio is 0.91.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. SMS Lifesciences India Ltd's debt-to-equity ratio is 0.10.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. SMS Lifesciences India Ltd's interest coverage ratio is 3.89.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. SMS Lifesciences India Ltd's DPS is ₹1.33.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. SMS Lifesciences India Ltd's EPS is 121.22.
(Source line: "Ratios as of 01 Sept 2026, based on last traded price of ₹1480. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2006
Headquarters: Hyderabad, Telangana
Core Offerings: Active Pharmaceutical Ingredients (APIs), Intermediates, Contract Manufacturing Services (CMS), Custom Synthesis
Stock Listing: NSE (SMSLIFE), BSE (540679)
Promoter: Dr. P. Ramesh Babu and Family
SMS Lifesciences India Ltd. was incorporated in 2006. In 2007, the company commissioned its first manufacturing facility at Kazipally. Over the years, it expanded its manufacturing capabilities and product portfolio, investing significantly in R&D. The company got listed on NSE and BSE in 2020 and continues to grow its presence in the API segment.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Active Pharmaceutical Ingredients (APIs) | 100% | N/A - Reported at consolidated level |
SMS Lifesciences primarily operates in the Active Pharmaceutical Ingredients (APIs) manufacturing segment, supplying critical raw materials to pharmaceutical companies.
The company's facilities are equipped for various chemical syntheses, including complex reactions and chiral chemistry, adhering to cGMP standards.
It also engages in Custom Synthesis and Contract Manufacturing for specific client requirements, leveraging its R&D capabilities.
Its product portfolio spans multiple therapeutic areas, serving both regulated and semi-regulated markets globally.
Dr. P. Ramesh Babu (Chairman & Managing Director): A highly experienced professional in the pharmaceutical industry with over 30 years of expertise in API manufacturing, R&D, and regulatory affairs, he is the driving force behind SMS Lifesciences' growth and strategic direction.
No major subsidiaries reported.
Rights Issue: 2021 (for capacity expansion); Bonus Issue: 2022 (1:5 ratio).
The SMS Lifesciences India Ltd share price today is ₹1480 on NSE (SMSLIFE), as of 12 Sept 2026.
As of 01 Sept 2026, SMS Lifesciences India Ltd share price is ₹1480, with previous close ₹1480. Today's range is ₹1480 to ₹1480. The 52-week range is ₹1480 to ₹1480.
As of today, SMS Lifesciences India Ltd's market cap is ₹444 crore (Small Cap).
SMS Lifesciences India Ltd's current P/E ratio is 23.93, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 38.
SMS Lifesciences India Ltd's current P/B ratio is 2.17.
SMS Lifesciences India Ltd's current dividend yield is 0.09%. Last dividend of ₹2.50 per share was declared on 29-May-2023.
SMS Lifesciences India Ltd's EPS (TTM) is ₹121.22.
SMS Lifesciences India Ltd. is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, primarily serving the pharmaceutical sector. The company specializes in developing and producing a diverse range of products across various therapeutic categories. Operating state-of-the-art facilities, it caters to both domestic and international markets, positioning itself as a key supplier in the global pharmaceutical supply chain.
SMS Lifesciences India Ltd is promoted by Dr. P. Ramesh Babu and Family, holding 88.73% as of 01 Sept 2026.
SMS Lifesciences India Ltd is listed on NSE (SMSLIFE) and BSE (540679). Its next quarterly results are expected on August 2024.
Adjusted Earnings Per Share (Adjusted EPS)
Capital Expenditures (CapEx)